- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2072
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antipsychotic polypharmacy prescribing and risk of hospital readmission ; volume:235 ; number:1 ; day:28 ; month:10 ; year:2017 ; pages:281-289 ; date:1.2018
Psychopharmacology ; 235, Heft 1 (28.10.2017), 281-289, 1.2018
- Schlagwort
-
Klinische Psychologie
Psychiatrie
Psychische Störung
- Urheber
-
Kadra, Giouliana
- Beteiligte Personen und Organisationen
-
Stewart, Robert
Shetty, Hitesh
MacCabe, James H.
Chang, Chin-Kuo
Kesserwani, Jad
Taylor, David
Hayes, Richard D.
SpringerLink (Online service)
- DOI
-
10.1007/s00213-017-4767-6
- URN
-
urn:nbn:de:1111-201803132802
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kadra, Giouliana
- Stewart, Robert
- Shetty, Hitesh
- MacCabe, James H.
- Chang, Chin-Kuo
- Kesserwani, Jad
- Taylor, David
- Hayes, Richard D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Antipsychotic prescribing patterns in Australia: a retrospective analysis
Recognizing and preventing unacknowledged prescribing errors associated with polypharmacy
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Antipsychotic polypharmacy in a regional health service: a population-based study
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process
The potential to quantify polypharmacy in older adult hospital inpatients using electronic prescribing software: a feasibility study
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Antipsychotic prescribing patterns in Australia: a retrospective analysis
Recognizing and preventing unacknowledged prescribing errors associated with polypharmacy
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Antipsychotic polypharmacy in a regional health service: a population-based study
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process
The potential to quantify polypharmacy in older adult hospital inpatients using electronic prescribing software: a feasibility study
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Antipsychotic prescribing patterns in Australia: a retrospective analysis
Recognizing and preventing unacknowledged prescribing errors associated with polypharmacy
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Antipsychotic polypharmacy in a regional health service: a population-based study
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process